Ignite Creation Date:
2024-05-05 @ 4:44 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00305162
Status:
TERMINATED
Last Update Posted:
2014-05-08
First Post:
2006-03-17
Brief Title:
A Clinical Trial to Demonstrate the Efficacy of Cangrelor
Sponsor:
The Medicines Company
Organization:
The Medicines Company
Study Overview
Official Title:
A Clinical Trial Comparing Cangrelor to Clopidogrel in Subjects Who Require Percutaneous Coronary Intervention PCI
Status:
TERMINATED
Status Verified Date:
2014-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Insufficient evidence of the clinical effectiveness of cangrelor
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PCI
Brief Summary:
The primary objective of this study is to demonstrate that the efficacy of cangrelor is superior or at least non-inferior to that of clopidogrel in subjects requiring PCI
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None